166154965	166154965	CD	B-NP	O
|	|	NN	I-NP	O
ASMC	ASMC	NN	I-NP	O
|	|	NN	I-NP	O
33771792	33771792	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
5217440	5217440	CD	B-NP	O
|	|	CC	I-NP	O
10/25/2006	10/25/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
troponin	troponin	NN	I-NP	I-protein
+	+	SYM	B-NP	O
ACS	ACS	NN	I-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
htn	htn	NN	B-NP	O
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/10/2006	10/10/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/5/2006	4/5/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
PARSON	PARSON	NN	B-NP	O
,	,	,	O	O
HERSCHEL	HERSCHEL	NN	B-NP	O
628-92-85-8	628-92-85-8	CD	I-NP	O
Me	Me	NNP	I-NP	O
Villesca	Villesca	NNP	I-NP	O
Lubhalubs	Lubhalubs	NNP	I-NP	O
,	,	,	O	O
Massachusetts	Massachusetts	NNP	B-NP	O
29939	29939	CD	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
8/20/06	8/20/06	CD	B-NP	O
AT	AT	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
EICHHORST	EICHHORST	NN	B-NP	O
,	,	,	O	O
TROY	TROY	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
PLAVIX	PLAVIX	CD	B-NP	O
-LRB-	-LRB-	NN	I-NP	B-DNA
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	I-DNA
-RRB-	-RRB-	HYPH	O	I-DNA
75	75	CD	B-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
DAILY	DAILY	NNP	I-NP	I-DNA
ECASA	ECASA	NNP	I-NP	I-DNA
325	325	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
DAILY	DAILY	NNP	I-NP	I-DNA
NEXIUM	NEXIUM	NNP	I-NP	I-DNA
-LRB-	-LRB-	NNP	I-NP	I-DNA
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	I-DNA
-RRB-	-RRB-	NNP	I-NP	I-DNA
20	20	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
DAILY	DAILY	NNP	I-NP	I-DNA
ADVAIR	ADVAIR	NNP	I-NP	I-DNA
DISKUS	DISKUS	NNP	I-NP	I-DNA
500/50	500/50	CD	I-NP	I-DNA
-LRB-	-LRB-	HYPH	I-NP	O
FLUTICASONE	FLUTICASONE	NN	I-NP	O
PROPIONATE	PROPIONATE	NN	I-NP	O
/	/	SYM	B-NP	O
...	...	:	O	B-protein
-RRB-	-RRB-	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
PUFF	PUFF	NN	I-NP	I-protein
INH	INH	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	NN	I-NP	I-protein
25	25	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
NPH	NPH	NNP	I-NP	I-protein
HUMAN	HUMAN	NNP	I-NP	I-protein
62	62	CD	I-NP	I-protein
UNITS	UNITS	NNP	I-NP	I-protein
SC	SC	NNP	I-NP	I-protein
QAM	QAM	NNP	I-NP	I-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
NPH	NPH	NNP	I-NP	I-protein
HUMAN	HUMAN	NNP	I-NP	I-protein
16	16	CD	I-NP	I-protein
UNITS	UNITS	NNP	I-NP	I-protein
SC	SC	NNP	I-NP	I-protein
QPM	QPM	NNP	I-NP	I-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
REGULAR	REGULAR	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
10	10	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
Take	Take	VB	B-VP	O
with	with	IN	B-PP	O
breakfast	breakfast	NN	B-NP	O
and	and	CC	I-NP	O
dinner	dinner	NN	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/12/06	9/12/06	CD	B-NP	O
by	by	IN	B-PP	O
NEIGHBOURS	NEIGHBOURS	NNP	B-NP	O
,	,	,	O	O
SANG	SANG	NNP	B-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NNP	B-NP	O
IMMEDIATE	IMMEDIATE	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
890721415	890721415	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/12/06	9/12/06	CD	B-NP	O
by	by	IN	B-PP	O
BRIDENBAUGH	BRIDENBAUGH	NNP	B-NP	O
,	,	,	O	O
CHRISTIAN	CHRISTIAN	NNP	B-NP	O
C.	C.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NN	B-NP	O
IV	IV	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
616409189	616409189	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/12/06	9/12/06	CD	B-NP	O
by	by	IN	B-PP	O
GULLAGE	GULLAGE	NN	B-NP	O
,	,	,	O	O
QUINTIN	QUINTIN	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
POTASSIUM	POTASSIUM	NN	B-NP	O
CHLORIDE	CHLORIDE	NN	I-NP	O
IV	IV	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
408714658	408714658	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/12/06	9/12/06	CD	B-NP	O
by	by	IN	B-PP	O
DERBYSHIRE	DERBYSHIRE	NN	B-NP	O
,	,	,	O	O
EMMITT	EMMITT	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NNP	B-NP	O
IMMEDIATE	IMMEDIATE	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
640752327	640752327	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
on	on	IN	B-PP	O
hctz	hctz	NN	B-NP	O
TOPROL	TOPROL	NN	I-NP	O
XL	XL	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

NITROGLYCERIN	NITROGLYCERIN	NN	B-NP	B-protein
1/150	1/150	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	O
0.4	0.4	CD	I-NP	B-DNA
MG	MG	NN	I-NP	I-DNA
-RRB-	-RRB-	HYPH	B-NP	I-DNA
1	1	CD	I-NP	I-DNA
TAB	TAB	NN	I-NP	I-DNA
SL	SL	NN	I-NP	I-DNA
q5min	q5min	NN	I-NP	I-DNA
x	x	SYM	B-NP	I-DNA
3	3	CD	I-NP	I-DNA
PRN	PRN	NN	I-NP	I-DNA
chest	chest	NN	I-NP	I-DNA
pain	pain	NN	I-NP	I-DNA
SIMVASTATIN	SIMVASTATIN	NN	I-NP	I-DNA
60	60	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
DAILY	DAILY	NNP	I-NP	I-DNA
Starting	Starting	NNP	I-NP	I-DNA
Today	Today	NNP	I-NP	I-DNA
-LRB-	-LRB-	NNP	I-NP	I-DNA
4/24	4/24	CD	I-NP	I-DNA
-RRB-	-RRB-	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

DIET	DIET	NN	B-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
RETURN	RETURN	NN	I-NP	O
TO	TO	NN	I-NP	O
WORK	WORK	NN	I-NP	O
:	:	:	O	O
IN	IN	NN	B-NP	O
1-2	1-2	CD	I-NP	O
WEEKS	WEEKS	NNP	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Remlinger	Remlinger	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
CH	CH	NNP	I-NP	O
Primary	Primary	NNP	I-NP	O
Care	Care	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Friday	Friday	NNP	B-NP	O
,	,	,	O	O
October	October	NNP	B-NP	O
,	,	,	O	O
12	12	CD	B-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
PM	PM	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Exercise	Exercise	NN	B-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
about	about	IN	B-PP	O
2wks	2wk	NNS	B-NP	O
,	,	,	O	O
CPHMC	CPHMC	NN	B-NP	O
cardiology	cardiology	NN	I-NP	O
will	will	MD	B-VP	O
call	call	VB	I-VP	O
to	to	TO	I-VP	O
arrange	arrange	VB	I-VP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Hessling	Hessling	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
KWICH	KWICH	NNP	I-NP	O
Cardiology	Cardiology	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
about	about	IN	B-PP	O
2wks	2wk	VBZ	O	O
-LRB-	-LRB-	NN	B-NP	B-protein
after	after	IN	B-PP	O
ETT	ETT	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
CSGH	CSGH	NN	B-NP	O
cardiology	cardiology	NN	I-NP	O
will	will	MD	B-VP	O
call	call	VB	I-VP	O
to	to	TO	I-VP	O
arrange	arrange	VB	I-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
TETRACYCLINE	TETRACYCLINE	NN	B-NP	O
ANALOGUES	ANALOGUES	VBZ	B-VP	O
ADMIT	ADMIT	NN	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Chest	Ch	JJS	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
hypertensive	hypertensive	JJ	B-NP	O
urgency	urgency	NN	I-NP	O
,	,	,	O	O
possible	possible	JJ	B-NP	O
ACS	ACS	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NN	B-NP	O
for	for	IN	B-PP	O
Causing	Cause	VBG	B-VP	O
Admission	Admission	NN	B-NP	B-protein
-RRB-	-RRB-	SYM	B-NP	I-protein
troponin	troponin	NN	I-NP	I-protein
+	+	SYM	I-NP	O
ACS	ACS	NN	I-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
htn	htn	NN	B-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
DM	DM	NNP	I-NP	O
,	,	,	O	O
Htn	Htn	NNP	B-NP	B-protein
,	,	,	O	O
h/o	h/o	NN	B-NP	O
prostatitis	prostatitis	NN	I-NP	O
,	,	,	O	O
h/o	h/o	NN	B-NP	O
syphilis	syphilis	NN	I-NP	O
,	,	,	O	O
asthma	asthma	NN	B-NP	O
,	,	,	O	O
h/o	h/o	NN	B-NP	O
PNA	PNA	NN	I-NP	O
,	,	,	O	O
osteoarthritis	osteoarthritis	NN	B-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
Cardiac	Cardiac	JJ	B-NP	O
cath	cath	NN	I-NP	O
:	:	:	O	O
80	80	CD	B-NP	O
%	%	NN	I-NP	O
occlusion	occlusion	NN	I-NP	O
L	L	NN	I-NP	O
cx	cx	NN	I-NP	O
,	,	,	O	O
stent	stent	JJ	B-ADJP	O
placed	place	VBN	B-VP	O
;	;	:	O	O
40	40	CD	B-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
proximal	proximal	JJ	I-NP	O
LAD	LAD	NN	I-NP	O
,	,	,	O	O
80	80	CD	B-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
mid/apical	mid/apical	JJ	I-NP	O
LAD	LAD	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
not	not	RB	B-NP	O
stented	stente	VBN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

OTHER	OTHER	NNP	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Echocardiogram	Echocardiogram	NNP	I-NP	O
:	:	:	O	O
EF	EF	NN	B-NP	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
no	no	DT	B-NP	O
regional	regional	JJ	I-NP	O
motion	motion	NN	I-NP	O
abn	abn	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
LVH	LVH	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
LA	LA	NN	I-NP	O
enlargement	enlargement	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
MR+TR	MR+TR	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
sig	sig	NN	I-NP	B-protein
change	change	NN	I-NP	O
from	from	IN	B-PP	O
2002	2002	CD	B-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
Left	Left	NNP	B-NP	O
Lower	Lower	NNP	I-NP	O
Chest	Chest	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
HPI	HPI	NNP	I-NP	O
:	:	:	O	O
68	68	CD	B-NP	O
yo	yo	NN	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
h/o	h/o	NN	B-NP	O
DM	DM	NN	I-NP	O
HTN	HTN	NN	I-NP	O
hyperlipidemia	hyperlipidemia	NN	I-NP	O
,	,	,	O	O
asthma	asthma	NN	B-NP	O
presented	present	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
with	with	IN	B-PP	O
L-sided	L-sided	JJ	B-NP	B-protein
chest/flank	chest/flank	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
usual	usual	JJ	I-NP	O
state	state	NN	I-NP	O
of	of	IN	B-PP	O
health	health	NN	B-NP	O
until	until	IN	B-SBAR	O
he	he	PRP	B-NP	O
awoke	awake	VBD	B-VP	O
from	from	IN	B-PP	O
bed	bed	NN	B-NP	O
to	to	TO	B-VP	O
urinate	urinate	VB	I-VP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Upon	Upon	IN	B-PP	O
standing	standing	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
felt	feel	VBD	B-VP	O
dull	dull	JJ	B-NP	O
CP	CP	NN	I-NP	B-DNA
.	.	.	O	O

lasted	last	VBN	B-VP	O
X	X	SYM	B-NP	O
7	7	CD	I-NP	O
hours	hour	NNS	I-NP	O
,	,	,	O	O
non-radiating	non-radiating	JJ	B-ADJP	O
,	,	,	O	O
located	located	JJ	B-ADJP	O
beneath	beneath	IN	B-PP	O
mid-clavicle	mid-clavicle	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
SOB	SOB	NN	I-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
N/V	N/V	NN	I-NP	O
,	,	,	O	O
did	do	VBD	B-VP	O
experience	experience	VB	I-VP	O
transient	transient	JJ	B-NP	O
positional	positional	JJ	I-NP	O
lighthededness	lighthededness	NN	I-NP	O
upon	upon	IN	B-PP	O
standing	standing	NN	B-NP	O
.	.	.	O	O

Pain	Pain	NNP	B-NP	O
persisted	persist	VBD	B-VP	O
for	for	IN	B-PP	O
several	several	JJ	B-NP	O
hours	hour	NNS	I-NP	O
before	before	IN	B-SBAR	O
he	he	PRP	B-NP	O
called	call	VBD	B-VP	O
his	his	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
RK	RK	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
around	around	IN	B-PP	O
6pm	6pm	NN	B-NP	O
.	.	.	O	O

Was	Wa	NNS	B-NP	B-protein
instructed	instruct	VBN	B-VP	O
to	to	TO	B-VP	O
go	go	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
home	home	NN	B-NP	O
he	he	PRP	B-NP	O
self-measured	self-measure	VBD	B-VP	O
SBP	SBP	NN	B-NP	B-protein
to	to	TO	B-VP	O
be	be	VB	I-VP	O
236	236	CD	B-NP	O
systolic	systolic	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
baseline	baseline	NN	I-NP	O
SBP	SBP	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
is	be	VBZ	B-VP	O
160-180	160-180	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
admitted	admit	VBD	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
not	not	RB	I-VP	O
taken	take	VBN	I-VP	O
BP	BP	NN	B-NP	O
meds	med	NNS	I-NP	O
for	for	IN	B-PP	O
several	several	JJ	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
reproducible	reproducible	JJ	B-ADJP	O
on	on	IN	B-PP	O
chest	chest	NN	B-NP	O
palpation	palpation	NN	I-NP	O
.	.	.	O	O

Initial	Initial	JJ	B-NP	O
biomarkers	biomarker	NNS	I-NP	O
:	:	:	O	O
TnI	TnI	NN	B-NP	O
0.11	0.11	CD	I-NP	O
,	,	,	O	O
CK	CK	NN	B-NP	B-cell_line
232	232	CD	I-NP	I-cell_line
,	,	,	O	O
MB	MB	NN	B-NP	B-protein
1.9	1.9	CD	I-NP	I-protein
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	NN	B-NP	O
started	start	VBN	B-VP	O
on	on	IN	B-PP	O
heparin	heparin	NN	B-NP	O
,	,	,	O	O
lopressor	lopressor	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
5mg	5mg	NN	I-NP	O
IV	IV	CD	I-NP	O
,	,	,	I-NP	O
25mg	25mg	CD	I-NP	O
PO	PO	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
ASA	ASA	NNP	B-NP	O
325	325	CD	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
relief	relief	NN	I-NP	O
from	from	IN	B-PP	O
TNG	TNG	NN	B-NP	O
gtt	gtt	NN	I-NP	O
,	,	,	O	O
relief	relief	NN	B-NP	O
from	from	IN	B-PP	O
morphine	morphine	NN	B-NP	O
sulfate	sulfate	NN	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	B-protein
risk	risk	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
:	:	:	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
+	+	SYM	B-NP	O
dislipidemia	dislipidemia	NN	I-NP	O
,	,	,	O	O
+	+	CC	O	O
family	family	NN	B-NP	O
hx	hx	NN	I-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
tob	tob	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

********************************	********************************	SYM	B-NP	O
PMH	PMH	NN	I-NP	O
:	:	:	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
,	,	,	O	O
Asthma	Asthma	NNP	B-NP	O
,	,	,	O	O
Knee	Knee	NNP	B-NP	O
surgery	surgery	NN	I-NP	O
9/28/03	9/28/03	CD	I-NP	O
,	,	,	O	O
Penile	Penile	JJ	B-NP	O
implant	implant	NN	I-NP	O
3/17	3/17	CD	I-NP	O
.	.	.	O	O

***************************	***************************	SYM	B-NP	O
ALL	ALL	NN	I-NP	O
:	:	:	O	O
NKDA	NKDA	NNP	B-NP	O
***************************	***************************	NNP	I-NP	O
Pre-admission	Pre-admission	NNP	I-NP	O
Medication	Medication	NNP	I-NP	O
List	List	NNP	I-NP	O
for	for	IN	B-PP	O
MEDOSCH	MEDOSCH	NNP	B-NP	O
,	,	,	O	O
SHAYNE	SHAYNE	NNP	B-NP	O
33771792	33771792	CD	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
LCH	LCH	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	O
68	68	CD	I-NP	O
M	M	NN	I-NP	O
1	1	CD	I-NP	O
.	.	.	O	O

Acetylsalicylic	Acetylsalicylic	JJ	B-NP	O
Acid	Acid	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Aspirin	Aspirin	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PO	PO	NNP	I-NP	O
81	81	CD	I-NP	O
MG	MG	NN	I-NP	O
QD	QD	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Hydrochlorothiazide	Hydrochlorothiazide	NN	B-NP	O
PO	PO	NN	I-NP	O
25	25	CD	I-NP	O
MG	MG	NN	I-NP	O
QD	QD	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

Insulin	Insulin	NNP	B-NP	O
Nph	Nph	NNP	I-NP	O
Human	Human	NNP	I-NP	O
SC	SC	NNP	I-NP	O
62	62	CD	I-NP	O
QAM	QAM	NNP	I-NP	O
,	,	,	O	O
16U	16U	NNP	B-NP	O
QPM	QPM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
BEFORE	BEFORE	NNP	I-NP	O
BREAKFAST	BREAKFAST	NNP	I-NP	O
AND	AND	CC	O	O
BEFORE	BEFORE	NN	B-NP	B-protein
SUPPER	SUPPER	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

Insulin	Insulin	NN	B-NP	B-protein
Regular	Regular	JJ	I-NP	O
Human	Human	JJ	I-NP	O
SC	SC	NN	I-NP	O
10U	10U	NN	I-NP	O
BID	BID	NN	I-NP	O
BEFORE	BEFORE	NN	I-NP	O
BREAKFAST	BREAKFAST	NN	I-NP	O
AND	AND	CC	I-NP	O
BEFORE	BEFORE	NN	I-NP	B-protein
SUPPER	SUPPER	NN	I-NP	I-protein
5	5	CD	I-NP	I-protein
.	.	.	O	O

Lisinopril	Lisinopril	NNP	B-NP	O
PO	PO	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NN	I-NP	O
QD	QD	NN	I-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

Verapamil	Verapamil	NN	B-NP	O
Hcl	Hcl	NN	I-NP	O
PO	PO	NN	I-NP	O
60	60	CD	I-NP	O
MG	MG	NN	I-NP	O
QD	QD	NN	I-NP	O
***************************	***************************	SYM	B-VP	O
Afebrile	Afebrile	NN	B-NP	O
,	,	,	O	O
HR	HR	NN	B-NP	B-DNA
54	54	CD	I-NP	I-DNA
BP	BP	NN	I-NP	I-DNA
124/70	124/70	CD	B-NP	I-DNA
,	,	,	O	O
Gen	Gen	NNP	B-NP	O
:	:	:	O	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
,	,	,	O	O
A	A	NNP	B-NP	B-protein
&	&	CC	I-NP	I-protein
O	O	NNP	I-NP	I-protein
X	X	NNP	I-NP	I-protein
3	3	CD	I-NP	I-protein
,	,	,	O	O
HEENT	HEENT	NNP	B-NP	O
PERRL	PERRL	NNP	I-NP	O
,	,	,	O	O
EOMI	EOMI	NNP	B-NP	O
,	,	,	O	O
anicteric	anicteric	JJ	B-NP	O
,	,	,	I-NP	O
OP	OP	NNP	I-NP	O
clear	clear	JJ	I-NP	O
,	,	,	I-NP	O
JVP	JVP	NN	I-NP	O
approx	approx	NN	I-NP	O
7	7	CD	I-NP	O
cm	cm	NN	I-NP	O
,	,	,	O	O
Carotids	Carotid	NNS	B-NP	O
full	full	JJ	B-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
bruits	bruit	NNS	I-NP	O
noted	note	VBD	B-VP	O
Lungs	Lung	NNS	B-NP	O
:	:	:	O	O
CTA	CTA	NN	B-NP	B-protein
bilaterally	bilaterally	RB	B-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
RRR	RRR	NN	B-NP	B-protein
S1	S1	NN	I-NP	I-protein
S2	S2	NN	I-NP	I-protein
split	split	NN	I-NP	I-protein
,	,	,	O	O
2/6	2/6	CD	B-NP	O
SEM	SEM	NNP	I-NP	O
RUSB	RUSB	NNP	I-NP	O
,	,	,	O	O
+	+	JJ	B-NP	O
s4	s4	NN	I-NP	O
,	,	,	O	O
PMI	PMI	NN	B-NP	O
displaced	displace	VBD	B-VP	O
Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
benign	benign	JJ	B-NP	O
Ext	Ext	NN	I-NP	O
no	no	DT	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
palpable	palpable	JJ	B-NP	O
DT/PT	DT/PT	NN	I-NP	O
pulses	pulse	NNS	I-NP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
:	:	:	O	O
L	L	NN	B-NP	O
midaxilary	midaxilary	JJ	I-NP	O
pain	pain	NN	I-NP	O
at	at	IN	B-PP	O
8-9	8-9	CD	B-NP	O
ribs	rib	NNS	I-NP	O
reproduced	reproduce	VBN	B-VP	O
upon	upon	IN	B-PP	O
palpation	palpation	NN	B-NP	O
****************************	****************************	SYM	B-NP	O
EKG	EKG	NN	I-NP	O
:	:	:	O	O
sinus	sinus	NN	B-NP	O
brady	brady	NN	I-NP	O
at	at	IN	B-PP	O
58bpm	58bpm	NN	B-NP	O
,	,	,	O	O
marked	marked	JJ	B-NP	O
first	first	JJ	I-NP	O
degree	degree	NN	I-NP	O
AV	AV	NN	I-NP	O
block	block	NN	I-NP	O
,	,	,	O	O
?	?	.	O	O

ant	ant	JJ	B-NP	O
septal	septal	JJ	I-NP	O
MI	MI	NN	I-NP	O
uncertain	uncertain	JJ	I-NP	O
duration	duration	NN	I-NP	O
.	.	.	O	O

****************************	****************************	SYM	B-NP	O
EVENTS	EVENTS	NNS	I-NP	O
:	:	:	O	O
5/21	5/21	CD	B-NP	O
-	-	HYPH	I-NP	O
CEs	CE	NNS	I-NP	O
trending	trend	VBG	B-VP	O
down	down	IN	B-ADVP	O
.	.	.	O	O

Cath	Cath	NN	B-NP	O
today	today	NN	B-NP	O
.	.	.	O	O

3VD	3VD	NN	B-NP	O
.	.	.	O	O

Cypher	Cypher	NN	B-NP	B-protein
stentx1	stentx1	NN	I-NP	I-protein
placed	place	VBN	B-VP	O
in	in	IN	B-PP	O
left	left	JJ	B-NP	O
cx	cx	NN	I-NP	O
.	.	.	O	O

80	80	CD	B-NP	O
%	%	NN	I-NP	O
mid	mid	JJ	I-NP	O
LCx	LCx	NN	I-NP	O
,	,	,	O	O
40	40	CD	B-NP	O
%	%	NN	I-NP	O
mid	mid	JJ	I-NP	O
LAD	LAD	NN	I-NP	O
,	,	,	O	O
total	total	JJ	B-NP	O
occ	occ	NN	I-NP	O
RCA	RCA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
small	small	JJ	I-NP	O
vessel	vessel	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
post	post	NN	B-NP	O
cath	cath	NN	I-NP	O
EKG	EKG	NN	I-NP	O
fine	fine	NN	I-NP	O
,	,	,	O	O
loaded	load	VBD	B-VP	O
w	w	NN	B-NP	O
/	/	SYM	B-NP	O
600mg	600mg	NN	I-NP	O
plavix	plavix	NN	I-NP	O
.	.	.	O	O

ECHO	ECHO	NN	B-NP	O
today	today	NN	I-NP	O
EF	EF	NN	I-NP	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
regional	regional	JJ	I-NP	O
wall	wall	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
LVH	LVH	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
LA	LA	NN	I-NP	O
enlargement	enlargement	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
MR	MR	NN	I-NP	B-protein
,	,	,	O	O
mild	mild	JJ	B-NP	O
TR	TR	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
change	change	NN	I-NP	O
since	since	IN	B-PP	O
5/26	5/26	CD	B-NP	O
ECHO	ECHO	NN	I-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
stay	stay	VB	I-VP	O
for	for	IN	B-PP	O
2	2	CD	B-NP	O
more	more	JJR	I-NP	O
days	day	NNS	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
25	25	CD	B-NP	O
beat	beat	JJ	I-NP	O
run	run	NN	I-NP	O
of	of	IN	B-PP	O
VT	VT	NN	B-NP	O
overnight	overnight	RB	B-ADVP	O
.	.	.	O	O

4/30	4/30	CD	B-NP	O
-	-	HYPH	I-NP	O
Doing	Do	VBG	B-VP	O
well	well	RB	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
3-4	3-4	CD	B-NP	O
beats	beat	NNS	I-NP	O
of	of	IN	B-PP	O
VT	VT	NN	B-NP	B-protein
x2	x2	NN	I-NP	I-protein
.	.	.	O	O

Likely	Likely	JJ	B-NP	O
D/C	D/C	NN	I-NP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
tomorrow	tomorrow	NN	B-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
need	need	VB	I-VP	O
post	post	NN	B-NP	O
D/C	D/C	NN	I-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
and	and	CC	O	O
cardiac	cardiac	JJ	B-NP	O
rehab	rehab	NN	I-NP	O
.	.	.	O	O

Likely	Likely	RB	B-ADVP	O
start	start	VB	B-VP	O
niacin	niacin	NN	B-NP	O
or	or	CC	I-NP	O
fenofibrate	fenofibrate	NN	I-NP	O
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
HDL	HDL	NN	B-NP	B-DNA
29	29	CD	I-NP	I-DNA
.	.	.	O	O

**************************	**************************	SYM	O	O
HOSPITAL	HOSPITAL	NN	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
is	be	VBZ	B-VP	O
68	68	CD	B-NP	O
yo	yo	NN	I-NP	O
male	male	JJ	I-NP	O
admitted	admit	VBN	B-VP	O
with	with	IN	B-PP	O
troponin	troponin	NN	B-NP	O
+	+	SYM	I-NP	O
ACS	ACS	NN	I-NP	O
,	,	,	O	O
hypertensive	hypertensive	JJ	B-NP	O
urgency	urgency	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
chest	chest	NN	B-NP	O
wall	wall	NN	I-NP	O
pain	pain	NN	I-NP	O
reprocducible	reprocducible	JJ	B-ADJP	O
upon	upon	IN	B-PP	O
palpation	palpation	NN	B-NP	O
.	.	.	O	O

Stent	Stent	JJ	B-NP	O
placed	place	VBN	I-NP	O
L	L	NN	I-NP	O
circumflex	circumflex	NN	I-NP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
Ischemia	Ischemia	NN	B-NP	O
:	:	:	O	O
Despite	Despite	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
reproducible	reproducible	JJ	B-ADJP	O
on	on	IN	B-PP	O
palpation	palpation	NN	B-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
mildly	mildly	RB	B-NP	O
elevated	elevated	JJ	I-NP	O
biomarkers	biomarker	NNS	I-NP	O
.	.	.	O	O

Started	Start	VBN	B-VP	O
on	on	IN	B-PP	O
Heparin	Heparin	NN	B-NP	O
,	,	,	O	O
IV	IV	CD	B-NP	O
lopressor	lopressor	NN	I-NP	O
+25	+25	CD	B-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
lopressor	lopressor	NN	I-NP	O
,	,	,	O	O
given	give	VBN	B-PP	O
ASA	ASA	NN	B-NP	O
325	325	CD	I-NP	O
.	.	.	O	O

Went	Went	NN	B-NP	O
for	for	IN	B-PP	O
cath	cath	NN	B-NP	B-protein
5/21	5/21	CD	I-NP	I-protein
,	,	,	O	O
found	find	VBN	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
3VD	3VD	NN	B-NP	O
:	:	:	O	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
occlusion	occlusion	NN	I-NP	O
R	R	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
small	small	JJ	I-NP	O
vessel	vessel	NN	I-NP	O
,	,	,	O	O
L	L	NN	B-NP	O
dom	dom	NN	I-NP	O
heart	heart	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
;	;	:	O	O
85	85	CD	B-NP	O
%	%	NN	I-NP	O
occlusion	occlusion	NN	I-NP	O
of	of	IN	B-PP	O
L.	L.	NNP	B-NP	O
cx	cx	NN	I-NP	O
--	--	:	O	O
1x	1x	CD	B-NP	O
cypher	cypher	NN	I-NP	O
stent	stent	NN	I-NP	O
placed	place	VBN	B-VP	O
,	,	,	O	O
restored	restore	VBD	B-VP	O
to	to	TO	B-PP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
TIMI3	TIMI3	NN	B-NP	B-protein
flow	flow	NN	I-NP	O
.	.	.	O	O

Also	Also	RB	B-NP	O
35	35	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
proximal	proximal	JJ	I-NP	O
LAD	LAD	NN	I-NP	O
and	and	CC	O	O
80	80	CD	B-NP	O
%	%	NN	I-NP	O
occ	occ	NN	I-NP	O
mid-apical	mid-apical	JJ	I-NP	O
LAD	LAD	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
not	not	RB	B-NP	O
stented	stente	VBN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Loaded	Load	VBN	B-VP	O
with	with	IN	B-PP	O
600mg	600mg	NN	B-NP	O
plavix	plavix	NN	I-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
continue	continue	VB	I-VP	O
on	on	IN	B-PP	O
75mg	75mg	NN	B-NP	O
plavix	plavix	NN	I-NP	O
for	for	IN	B-PP	O
>	>	SYM	B-NP	O
1yr	1yr	NN	I-NP	O
,	,	,	O	O
continue	continue	VBP	B-VP	O
325mg	325mg	CD	B-NP	O
ASA	ASA	NNP	I-NP	O
.	.	.	O	O

Started	Start	VBN	B-VP	O
on	on	IN	B-PP	O
Zocor	Zocor	NNP	B-NP	O
at	at	IN	B-PP	O
40	40	CD	B-NP	O
,	,	,	O	O
will	will	MD	B-VP	O
increase	increase	VB	I-VP	O
to	to	TO	B-PP	O
60mg	60mg	NN	B-NP	O
QD	QD	NN	I-NP	O
at	at	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
had	have	VBD	B-VP	O
LDL	LDL	NN	B-NP	B-protein
77	77	CD	I-NP	I-protein
with	with	IN	B-PP	O
low	low	JJ	B-NP	O
HDL	HDL	NN	I-NP	O
,	,	,	O	O
PCP	PCP	NN	B-NP	B-protein
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
lipid	lipid	NN	B-NP	O
panel	panel	NN	I-NP	O
,	,	,	O	O
decision	decision	NN	B-NP	O
to	to	TO	B-VP	O
treat	treat	VB	I-VP	O
with	with	IN	B-PP	O
niacin	niacin	NN	B-NP	O
vs	vs	IN	B-PP	O
fenofibrate	fenofibrate	NN	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
deferred	defer	VBN	I-VP	O
to	to	TO	B-PP	O
PCP	PCP	NN	B-NP	B-protein
who	who	WP	B-NP	O
will	will	MD	B-VP	O
f/u	f/u	VB	I-VP	O
within	within	IN	B-PP	O
1wk	1wk	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
will	will	MD	B-VP	O
also	also	RB	I-VP	O
need	need	VB	I-VP	O
f/u	f/u	NN	B-NP	O
ETT	ETT	NN	I-NP	O
to	to	TO	B-VP	O
eval	eval	VB	I-VP	O
any	any	DT	B-NP	O
residual	residual	JJ	I-NP	O
ischemic	ischemic	JJ	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
need	need	NN	B-NP	O
of	of	IN	B-PP	O
intervention	intervention	NN	B-NP	O
in	in	IN	B-PP	O
distal	distal	JJ	B-NP	O
LAD	LAD	NN	I-NP	O
lesion	lesion	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
this	this	DT	B-NP	O
test	test	NN	I-NP	O
and	and	CC	I-NP	O
f/u	f/u	NN	I-NP	O
cardiology	cardiology	NN	I-NP	O
appointment	appointment	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
arranged	arrange	VBN	I-VP	O
by	by	IN	B-PP	O
BC	BC	NN	B-NP	O
cardiology	cardiology	NN	I-NP	O
for	for	IN	B-PP	O
about	about	RB	B-VP	O
2wks	2wk	VBZ	I-VP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
also	also	RB	B-ADVP	O
d/c	d/c	NN	B-NP	O
on	on	IN	B-PP	O
25mg	25mg	NN	B-NP	O
Toprol	Toprol	NNP	I-NP	O
XL	XL	NNP	I-NP	O
and	and	CC	O	O
40mg	40mg	CD	B-NP	O
lisinopril	lisinopril	NN	I-NP	O
,	,	,	O	O
rx	rx	NN	B-NP	O
for	for	IN	B-PP	O
SL	SL	NN	B-NP	O
nitro	nitro	NN	I-NP	O
given	give	VBN	B-VP	O
.	.	.	O	O

Pump	Pump	NNP	B-NP	O
:	:	:	O	O
Echo	Echo	NNP	B-NP	O
revealed	reveal	VBD	B-VP	O
EF	EF	NN	B-NP	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
regional	regional	JJ	I-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
abnormality	abnormality	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
LVH	LVH	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
TR+MR	TR+MR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
2002	2002	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
has	have	VBZ	B-VP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
severe	severe	JJ	B-NP	O
htn	htn	NN	I-NP	O
.	.	.	O	O

CCb	CCb	NN	B-NP	O
d/c	d/c	NN	I-NP	O
'd	'd	NN	I-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
started	start	VBD	B-VP	O
on	on	IN	B-PP	O
lopressor	lopressor	NN	B-NP	O
12.5	12.5	CD	I-NP	O
BID	BID	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
d/c	d/c	NN	I-NP	O
'd	'd	VBD	B-VP	O
on	on	IN	B-PP	O
25mg	25mg	NN	B-NP	B-protein
toprol	toprol	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Cont	Cont	JJ	B-NP	O
HCTZ	HCTZ	NN	I-NP	O
25	25	CD	I-NP	O
QD	QD	NN	I-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
40mg	40mg	CD	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

SBP	SBP	NN	B-NP	B-protein
elevated	elevate	VBD	B-VP	O
to	to	TO	B-PP	O
160	160	CD	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
further	further	JJ	B-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
regimen	regimen	NN	B-NP	O
deferred	defer	VBN	B-VP	O
for	for	IN	B-PP	O
adjustment	adjustment	NN	B-NP	O
by	by	IN	B-PP	O
PCP	PCP	NN	B-NP	B-protein
who	who	WP	B-NP	O
should	should	MD	B-VP	O
follow	follow	VB	I-VP	O
closely	closely	RB	B-ADVP	O
.	.	.	O	O

Given	Give	VBN	B-NP	O
low	low	JJ	I-NP	O
HR	HR	NN	I-NP	O
,	,	,	O	O
may	may	MD	B-VP	O
consider	consider	VB	I-VP	O
restart	restart	NN	B-NP	O
of	of	IN	B-PP	O
CCb	CCb	NN	B-NP	B-protein
rather	rather	RB	B-CONJP	O
than	than	IN	I-CONJP	O
uptitration	uptitration	NN	B-NP	O
or	or	CC	I-NP	O
toprol	toprol	NN	I-NP	O
.	.	.	O	O

Rhythm	Rhythm	NN	B-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
had	have	VBD	B-VP	O
25	25	CD	B-NP	O
beat	beat	NN	I-NP	O
run	run	NN	I-NP	O
of	of	IN	B-PP	O
asymptomatic	asymptomatic	JJ	B-NP	O
VT	VT	NN	I-NP	O
in	in	IN	B-PP	O
setting	setting	NN	B-NP	O
of	of	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
cath	cath	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
events	event	NNS	I-NP	O
24hr	24hr	VBP	B-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
d/c	d/c	NN	B-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
occ	occ	NN	I-NP	B-protein
PVC	PVC	NN	I-NP	I-protein
couplets	couplet	NNS	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

On	On	IN	B-PP	O
beta-blocker	beta-blocker	NN	B-NP	O
,	,	,	O	O
PCP	PCP	NN	B-NP	B-protein
should	should	MD	B-VP	O
follow	follow	VB	I-VP	O
lytes	lyte	NNS	B-NP	O
after	after	IN	B-PP	O
d/c	d/c	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

ENDO	ENDO	NN	B-NP	B-protein
:	:	:	O	O
Pt	Pt	NN	B-NP	O
with	with	IN	B-PP	O
poorly-controlled	poorly-controlled	JJ	B-NP	O
DM	DM	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
NPH	NPH	NNP	B-NP	O
BID	BID	NNP	I-NP	O
plus	plus	CC	O	O
Aspart	Aspart	NNP	B-NP	O
AC+HS	AC+HS	NNP	I-NP	O
during	during	IN	B-PP	O
hospital	hospital	NN	B-NP	O
stay	stay	NN	I-NP	O
,	,	,	O	O
will	will	MD	B-VP	O
discharge	discharge	VB	I-VP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
,	,	,	O	O
needs	need	VBZ	B-VP	O
f/u	f/u	NN	B-NP	O
with	with	IN	B-PP	O
PCP	PCP	NN	B-NP	B-protein
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Pulm	Pulm	NN	B-NP	O
:	:	:	O	O
History	History	NN	B-NP	O
of	of	IN	B-PP	O
asthma	asthma	NN	B-NP	O
,	,	,	O	O
wheezing	wheeze	VBG	B-VP	O
during	during	IN	B-PP	O
hospital	hospital	NN	B-NP	O
stay	stay	NN	I-NP	O
improved	improve	VBN	B-VP	O
on	on	IN	B-PP	O
advair	advair	NN	B-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
continue	continue	VB	I-VP	O
500/50mg	500/50mg	CD	B-NP	O
1puff	1puff	NN	I-NP	O
BID	BID	NN	I-NP	O
for	for	IN	B-PP	O
now	now	RB	B-NP	O
,	,	,	O	O
PCP	PCP	NN	B-NP	B-protein
should	should	MD	B-VP	O
address	address	VB	I-VP	O
need	need	NN	B-NP	O
for	for	IN	B-PP	O
continued	continued	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

GI	GI	LS	B-LST	O
.	.	.	O	O

Started	Start	VBN	B-VP	O
on	on	IN	B-PP	O
20mg	20mg	NN	B-NP	O
nexium	nexium	JJ	I-NP	O
given	give	VBN	I-NP	O
treatment	treatment	NN	I-NP	O
with	with	IN	B-PP	O
325mg	325mg	NN	B-NP	O
ASA	ASA	NN	I-NP	O
,	,	,	O	O
PCP	PCP	NN	B-NP	B-protein
should	should	MD	B-VP	O
evaluate	evaluate	VB	I-VP	O
if	if	IN	B-SBAR	O
continued	continue	VBN	B-NP	O
treatment	treatment	NN	I-NP	O
needed	need	VBN	B-VP	O
.	.	.	O	O

FULL	FULL	NN	B-NP	O
CODE	CODE	NN	I-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
continue	continue	VB	B-VP	O
your	your	PRP$	B-NP	O
new	new	JJ	I-NP	O
medications	medication	NNS	I-NP	O
:	:	:	O	O
Plavix	Plavix	NNP	B-NP	O
,	,	,	O	O
Toprol	Toprol	NNP	B-NP	O
XL	XL	NNP	I-NP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
,	,	,	O	O
asprin	asprin	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
325mg	325mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
nitroglycerin	nitroglycerin	NN	B-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
,	,	,	O	O
advair	advair	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
nexium	nexium	NN	B-NP	O
.	.	.	O	O

Continue	Continue	IN	B-PP	O
all	all	DT	B-NP	O
your	your	PRP$	I-NP	O
other	other	JJ	I-NP	O
medications	medication	NNS	I-NP	O
except	except	IN	B-PP	O
verapamil	verapamil	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
you	you	PRP	B-NP	O
should	should	MD	B-VP	O
stop	stop	VB	I-VP	O
for	for	IN	B-PP	O
now	now	RB	B-NP	O
.	.	.	O	O

Continue	Continue	VB	B-VP	O
your	your	PRP$	B-NP	O
home	home	NN	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
.	.	.	O	O

Your	Your	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
may	may	MD	B-VP	O
adjust	adjust	VB	I-VP	O
these	these	DT	B-NP	O
medications	medication	NNS	I-NP	O
at	at	IN	B-PP	O
your	your	PRP$	B-NP	O
first	first	JJ	I-NP	O
visit	visit	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
will	will	MD	B-VP	O
be	be	VB	I-VP	O
contacted	contact	VBN	I-VP	O
by	by	IN	B-PP	O
WH	WH	NN	B-NP	O
cardiology	cardiology	NN	I-NP	O
to	to	TO	B-VP	O
set	set	VB	I-VP	O
up	up	RP	B-PRT	O
a	a	DT	B-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
and	and	CC	O	O
office	office	NN	B-NP	O
visit	visit	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
very	very	RB	B-ADJP	O
important	important	JJ	I-ADJP	O
to	to	TO	B-VP	O
keep	keep	VB	I-VP	O
these	these	DT	B-NP	O
appointments	appointment	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
hear	hear	VB	I-VP	O
from	from	IN	B-PP	O
their	their	PRP$	B-NP	O
office	office	NN	I-NP	O
please	please	NN	I-NP	O
call	call	NN	I-NP	O
SEMC	SEMC	NN	I-NP	O
cardiology	cardiology	NN	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
any	any	DT	B-NP	O
recurrent	recurrent	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
try	try	VB	B-VP	O
nitroglycerin	nitroglycerin	NN	B-NP	B-protein
tabs	tab	NNS	I-NP	I-protein
as	as	IN	B-SBAR	O
directed	direct	VBN	B-VP	O
and	and	CC	O	O
notify	notify	VB	B-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
you	you	PRP	B-NP	O
can	can	MD	B-VP	O
not	not	RB	I-VP	O
reach	reach	VB	I-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
,	,	,	O	O
please	please	VB	B-INTJ	O
go	go	VB	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ED	ED	NNP	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
--	--	:	O	O
F/u	F/u	NN	B-NP	O
with	with	IN	B-PP	O
PCP	PCP	NN	B-NP	B-protein
,	,	,	O	O
who	who	WP	B-NP	O
will	will	MD	B-VP	O
address	address	VB	I-VP	O
BP	BP	NN	B-NP	B-protein
management	management	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
may	may	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
restart	restart	VB	I-VP	O
CCB	CCB	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
lipids	lipid	NNS	B-NP	O
-LRB-	-LRB-	VBP	B-VP	O
need	need	NN	B-NP	O
for	for	IN	B-PP	O
fenofibrate	fenofibrate	NN	B-NP	O
vs	vs	IN	B-PP	O
nicacin	nicacin	NN	B-NP	O
,	,	,	O	O
adjustment	adjustment	NN	B-NP	O
of	of	IN	B-PP	O
statin	statin	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Optimization	Optimization	NN	B-NP	O
of	of	IN	B-PP	O
insulin	insulin	NN	B-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
,	,	,	O	O
need	need	VBP	B-VP	O
to	to	TO	I-VP	O
re-evaluate	re-evaluate	VB	I-VP	O
asthma	asthma	NN	B-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

--	--	:	B-NP	O
F/u	F/u	NN	I-NP	O
ETT	ETT	NN	I-NP	O
and	and	CC	O	O
office	office	NN	B-NP	O
visit	visit	NN	I-NP	O
with	with	IN	B-PP	O
PHO	PHO	NN	B-NP	O
cardiology	cardiology	NN	I-NP	O
who	who	WP	B-NP	O
will	will	MD	B-VP	O
address	address	VB	I-VP	O
need	need	NN	B-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
revascularization	revascularization	NN	I-NP	O
of	of	IN	B-PP	O
LAD	LAD	NN	B-NP	O
lesions	lesion	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
PHELTS	PHELTS	NNP	B-NP	O
,	,	,	O	O
BENNETT	BENNETT	NNP	B-NP	O
I.	I.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
RZ63	RZ63	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
8/20/06	8/20/06	CD	I-NP	O
@	@	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
43	43	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

